Kowloon, China

Siu Kie Au

This inventor holds 1 USPTO granted patent. Top assignees: Queen Elizabeth Hospital, Vermillion Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siu Kie Au. Retrieved from https://idiyas.com/inventor/siu-kie-au

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Siu Kie Au: Innovator in Lung Cancer Diagnostics

Introduction

Siu Kie Au is a notable inventor based in Kowloon, China. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. His innovative work has the potential to improve the early detection and treatment of this serious disease.

Latest Patents

Siu Kie Au holds a patent for "Serum biomarkers in lung cancer." This patent outlines certain biomarkers and biomarker combinations that are useful in qualifying lung cancer status in a subject. The diagnostic methodology he developed employs these biomarkers and combinations to detect whether a subject has lung cancer, which can lead to timely and effective treatment options.

Career Highlights

Throughout his career, Siu Kie Au has worked with reputable institutions, including Queen Elizabeth Hospital and Vermillion Corporation. His experience in these organizations has allowed him to refine his expertise in medical diagnostics and contribute to advancements in lung cancer detection.

Collaborations

Siu Kie Au has collaborated with notable colleagues, including Timothy Tak Chun Yip and Chi Shing Cho. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the medical field.

Conclusion

Siu Kie Au's work in developing diagnostic methodologies for lung cancer showcases his commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…